A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.
Vaccine
; 36(32 Pt B): 4880-4889, 2018 08 06.
Article
in En
| MEDLINE
| ID: mdl-30037478
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Shigella sonnei
/
Vaccines, Attenuated
/
Shigella Vaccines
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Humans
/
Middle aged
Language:
En
Journal:
Vaccine
Year:
2018
Document type:
Article